Drug Topics
JUNE 21, 2024
In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.
Pharmacy Times
JUNE 21, 2024
The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible, newly diagnosed multiple myeloma (NDMM TI).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 21, 2024
Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.
STAT
JUNE 21, 2024
ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday. All but one reduced or eliminated the need to inject insulin over those three months and three people followed for one year no longer needed to inject insulin at all.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 21, 2024
With improved technology and innovations for diabetes, it is essential for health care providers and health agencies to collaborate to combat rising rates of diabetes.
STAT
JUNE 21, 2024
As a toddler, Veronica Ayala loved Fridays. At 5 o’clock sharp, her mom whisked her away from the grim Moody State School for Cerebral Palsied Children for a 48-hour reprieve. Ayala’s house was mere minutes away, but the doctors insisted that she had to live at the Galveston, Texas institution during the week so she could learn how to walk.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JUNE 21, 2024
WASHINGTON — A House panel is exploring holding a vote on scaled-back versions of two major health care bills that would expand Medicare’s coverage of cancer screening tests and hugely popular weight loss drugs, five sources familiar with the planning told STAT. Full Medicare coverage for both items has broad bipartisan support, but the expansion has been hampered by the likely exorbitant price tags to the federal government.
Pharmacy Times
JUNE 21, 2024
There are numerous challenges with cell and gene therapies in oncology, such as accessibility, cost, and prior authorizations, as well as the need for improved education and training within the oncology community.
STAT
JUNE 21, 2024
ORLANDO — The United States is at a critical juncture in its efforts to treat chronic diseases, particularly type 2 diabetes, and now has a chance to change the dangerous trajectory it’s currently following, FDA Commissioner Robert Califf said Friday. “The U.S. is leading the world in technology development, innovation, new gadgets of all kinds, new drugs, you name it,” he said.
Pharmacy Times
JUNE 21, 2024
Tim Mok, PharmD, BCOP, BCPS, discusses innovative therapies that are changing the treatment options available for patients with hematologic malignancies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JUNE 21, 2024
A jury has found Stanford University and Stanford Health Care liable for millions of dollars in damages to a longtime employee who sued the institution over its handling of racial harassment and discrimination against her a decade ago. After a seven-week trial, the jury ordered the award to be $20 million, but the Alameda County Superior Court concluded last week the award should be reduced to $10 million.
Fierce Pharma
JUNE 21, 2024
Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Dise | Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC) has taken flight.
STAT
JUNE 21, 2024
Danyel Smith has served 21 years of a life sentence at Dooly Correctional Facility in Unadilla, Georgia, for the 2003 murder of his two-month-old son, Chandler. The sole evidence against him at trial was the testimony of three physicians who said that child abuse — in this case shaken baby syndrome — was the only explanation for his son’s symptoms.
Fierce Healthcare
JUNE 21, 2024
There is an old saying that if you do not make time for your wellness, you will be forced to make time for your illness. | The time has come to recognize the power of primary care to lead transformation of the U.S. healthcare system.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JUNE 21, 2024
Kaiser Permanente on Friday announced the next deal to build out its Risant Health network of health systems. Risant plans to acquire North Carolina’s Cone Health, a Greensboro, N.C.-based system with four acute-care hospitals, more than 700 doctors, and — crucially for Risant — an accountable care organization and a health plan.
Fierce Pharma
JUNE 21, 2024
Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s | Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s National Health Service (NHS).
STAT
JUNE 21, 2024
Outside of North Carolina, most people probably haven’t heard of Cone Health. But the relatively small system has an outsized reputation for keeping locals healthy and out of hospitals, according to the CEO of the health care network that struck a deal to acquire it. Improving health outcomes is the stated mission of that network, called Risant Health.
Fierce Healthcare
JUNE 21, 2024
Telehealth startup Done said it "disagrees" with the criminal charges filed last week against its founder, Ruthia He, and David Brody, M.D., and plans to continue operating. | Telehealth startup Done said it "disagrees" with the criminal charges filed last week against its founder, Ruthia He, and David Brody, M.D. and plans to continue operating.
STAT
JUNE 21, 2024
Vendors of electronic health records and other health technology platforms have begun to publicize and demonstrate “patients like mine” capabilities, which insert analytics distilled from EHR data into the physician workflow to guide clinical decisions. While these implementations could be helpful, simple analytics must not be passed off as evidence, and care must be taken to rigorously implement and vet these tools to avoid the negative clinical and cost outcomes associated with i
pharmaphorum
JUNE 21, 2024
Explore the latest advancements in genomics and sequencing technologies, and learn how next-generation data management tools are transforming genomic research and applications in this new genomic frontier.
The Checkup by Singlecare
JUNE 21, 2024
If you’re managing Type 2 diabetes , choosing foods that help regulate blood glucose levels is essential. According to the American Diabetes Association , the best food choices for people with diabetes include whole grains, lean proteins, healthy fats, and non-starchy vegetables. Foods that are high in fiber and low in sugar are good snack options for individuals with diabetes because they help prevent rapid increases in blood sugar levels, improve heart health, and assist with weight mana
STAT
JUNE 21, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Buenos dias! Writing from one of the more unique locations in my tenure as a Readout author… Hola from a mercado in Mexico City. On tap today: Early studies show that checkpoint inhibitors may be more effective if combined with JAK inhibitors.
Pharmacy Times
JUNE 21, 2024
Presenters at the American Diabetes Association 84th Scientific Sessions, analyzed potential developments in treatment for patients with diabetes and diabetic kidney disease.
STAT
JUNE 21, 2024
A federal judge has sided with a powerful hospital lobby in a legal battle with regulators over hospitals’ use of third-party website trackers to gather details about visitors’ online behavior. North Texas U.S. District Court Judge Mark Pittman ruled that federal guidance limiting hospital websites’ use of these trackers exceeds the Health and Human Services Department’s authority under HIPAA, according to an opinion filed Thursday.
Fierce Pharma
JUNE 21, 2024
In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.< | In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.
STAT
JUNE 21, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharmacy Times
JUNE 21, 2024
Pharmacy Times will be at McKesson ideaShare 2024 Conference in New Orleans, Louisiana from June 23 to June 26, 2024.
STAT
JUNE 21, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, appears quite modest. We hope to tidy up around the castle, promenade with the official mascots and hold another listening party, where the rotation will likely include this , this , this , this and this.
Pharmacy Times
JUNE 21, 2024
American Diabetes Association Scientific Sessions speaker Ivan de Araujo emphasizes the importance of the pharmacist’s role in diabetes care and his hopes for the future of care.
Fierce Pharma
JUNE 21, 2024
For more than a decade, argenx has sought to apply its novel antibody fragment treat | Argenx's Vyvgart has won approval to treat its second indication in the U.S. and its third globally after the U.S. FDA cleared the med to treat the rare and debilitating peripheral nervous system disease chronic inflammatory demyelinating polyneuropathy (CIDP).
European Pharmaceutical Review
JUNE 21, 2024
Gilead Sciences ’ twice-yearly injectable HIV-1 capsid inhibitor enabled 100 percent efficacy for investigational use of HIV prevention in cisgender women. This is according to interim analysis topline results of the Phase III PURPOSE 1 trial. Lenacapavir showed superiority to once-daily oral Truvada ® (emtricitabine 200mg and tenofovir disoproxil fumarate 300mg; F/TDF) and background HIV incidence (bHIV).
Fierce Healthcare
JUNE 21, 2024
Kaiser Permanente’s Risant Health has named North Carolina’s Cone Health as the second acquisition target on its path toward a multisystem, multiregional value-based care entity. | The definitive agreement to purchase the $2.8 billion North Carolina nonprofit comes shortly after the value-based care subsidiary completed its deal for Geisinger Health.
Pharmaceutical Technology
JUNE 21, 2024
Trial investigators anticipate that the FDA will decide on approval for linvoseltamab in relapsed/refractory multiple myeloma by the end of 2024.
Pharmaceutical Commerce
JUNE 21, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Expert insights. Personalized for you.
223 
Let's personalize your content